Pharmaceutical Contract Packaging

Pharmaceutical Contract Packaging Market Outlook

The global pharmaceutical contract packaging market is projected to reach approximately USD 100 billion by 2035, growing at a CAGR of around 8.5% during the forecast period 2025-2035. This growth is primarily driven by the increasing demand for pharmaceutical products, which has been significantly influenced by the global aging population and the rising prevalence of chronic diseases. Additionally, advancements in packaging technologies that enhance product shelf life and improve patient safety are further fueling the market's expansion. The growing trend of outsourcing among pharmaceutical and biotech companies to reduce operational costs and focus on core competencies has also propelled the demand for contract packaging services. Furthermore, the rise in regulatory compliance and the need for effective packaging solutions that ensure product security are vital factors contributing to market growth.

Growth Factor of the Market

The pharmaceutical contract packaging market benefits from several transformative growth factors that enhance its appeal to multinational pharmaceutical companies and local producers alike. One of the most significant growth drivers is the increasing number of pharmaceutical products that require specialized packaging, designed to meet stringent regulatory standards. This growing complexity necessitates the expertise of contract packaging providers who can deliver customized solutions tailored to specific needs. Furthermore, the shift towards patient-centric packaging, which emphasizes user-friendliness and adherence to medication regimens, is gaining traction and driving demand. Innovations in smart packaging technologies, such as RFID tags and QR codes for tracking and tracing products, are also becoming pivotal in meeting both consumer needs and regulatory requirements. Moreover, the escalating focus on sustainability in packaging materials is prompting contract packagers to explore eco-friendly options, thereby appealing to environmentally conscious consumers and companies. Collectively, these factors are fostering a robust growth environment for the pharmaceutical contract packaging market.

Key Highlights of the Market

• Robust market growth projected at a CAGR of 8.5% from 2025 to 2035.
• Increased outsourcing of packaging services among pharmaceutical companies to enhance operational efficiency.
• Growth in demand for sustainability-driven packaging solutions to meet environmental standards.
• Technological advancements in packaging, including smart and interactive packaging systems.
• Expanding market presence in developing regions, particularly Asia Pacific, due to increasing healthcare investments.

By Service Type

Primary Packaging:

Primary packaging plays a crucial role in protecting pharmaceutical products from environmental factors and ensuring product safety and efficacy. This packaging type is designed to come into direct contact with the drug, thus requiring precise specifications and high-quality materials to prevent contamination. As pharmaceutical companies increasingly focus on patient safety and product integrity, the demand for primary packaging solutions such as blisters, bottles, and vials is witnessing substantial growth. Contract packaging companies are continuously innovating to provide customized primary packaging options that meet the varied requirements of different pharmaceutical products, thereby enhancing their market relevance and competitiveness.

Secondary Packaging:

Secondary packaging serves as an additional layer of protection and branding for pharmaceutical products. This type of packaging typically includes boxes, cartons, and shrink wraps that hold the primary packaging together. The increasing emphasis on branding and consumer engagement within the pharmaceutical sector has propelled the demand for aesthetically pleasing secondary packaging designs. Moreover, secondary packaging solutions are instrumental in aiding logistics and distribution processes by ensuring that products are safely transported and remain intact during shipping. As pharmaceutical firms look to enhance their product visibility and appeal, contract packagers are responding with innovative and efficient secondary packaging solutions that can optimize the supply chain.

Tertiary Packaging:

Tertiary packaging is essential for bulk handling and distribution of pharmaceutical products. It encompasses larger containers and pallets used during the transportation of goods to wholesalers and retailers. With the growing complexity of global supply chains, the demand for effective tertiary packaging solutions has surged to ensure the safe and efficient transport of pharmaceuticals. Contract packaging companies are focusing on developing robust tertiary packaging options that protect products during transit while also considering factors such as space optimization and cost-effectiveness. As logistics becomes increasingly sophisticated, the relevance of tertiary packaging in safeguarding product integrity and ensuring timely delivery cannot be overstated.

Labeling and Kitting:

Labeling and kitting services are integral components of the pharmaceutical contract packaging market, ensuring compliance with regulatory requirements and enhancing product usability. Effective labeling provides crucial information about the product, including dosage instructions, expiration dates, and warnings, which are essential for consumer safety. Additionally, kitting services, which involve assembling various components into a single package, are becoming increasingly popular in the pharmaceutical sector, especially for combination products and multi-pack offerings. Contract packaging providers are leveraging advanced technologies to offer precision labeling and efficient kitting solutions that cater to the specific needs of pharmaceutical companies while maintaining high-quality standards.

Others:

The "Others" category encompasses various specialized services within the pharmaceutical contract packaging market, such as serialization, tamper-evident packaging, and cold chain packaging. Serialization has become a critical component in combating counterfeit drugs, with many countries implementing regulations that require products to have unique identifiers. Tamper-evident packaging is also rising in prominence as it enhances product security, ensuring consumers that the integrity of the product has not been compromised. Cold chain packaging is vital for temperature-sensitive pharmaceuticals, particularly biologics and vaccines, which require strict temperature control throughout the supply chain. Contract packaging companies are increasingly investing in these specialized services to address the evolving needs of pharmaceutical manufacturers.

By Packaging Type

Blisters:

Blister packaging has gained traction in the pharmaceutical sector due to its ability to provide excellent protection against moisture and contamination while presenting an organized dosage format. This packaging type allows for the secure containment of tablets and capsules, making it easier for patients to identify their medications and adhere to prescribed regimens. The demand for blister packaging is expected to grow significantly, driven by the increasing prevalence of chronic diseases requiring long-term medication. As contract packaging companies innovate with new materials and designs, blister packaging will likely remain a key segment in the pharmaceutical contract packaging market.

Bottles:

Bottles are a traditional yet essential packaging solution in the pharmaceutical industry, primarily used for liquid medications, including syrups and suspensions. They offer versatility in sizes and materials, allowing for customization based on specific product requirements. The rising consumer preference for liquid formulations, especially for pediatric and geriatric patients, is a significant driver of the bottle packaging segment's growth. Additionally, advancements in bottle design, such as child-resistant features and user-friendly dispensing mechanisms, are enhancing their appeal. As the demand for liquid pharmaceuticals continues to rise, the contract packaging market for bottles is expected to flourish.

Pouches:

Pouches are increasingly becoming a popular choice for pharmaceutical packaging due to their lightweight and space-efficient nature. They are particularly favored for single-dose applications and over-the-counter medications. The flexibility and convenience of pouches make them ideal for various products, from powders to granules, enhancing consumer accessibility. Furthermore, the trend toward sustainability is driving the adoption of pouches made from eco-friendly materials, aligning with the growing consumer demand for environmentally responsible packaging. As pharmaceutical companies look to innovate and differentiate their products, pouches are poised to capture a larger share of the contract packaging market.

Tubes:

Tubes are widely used in the packaging of topical medications, ointments, and creams, offering an effective barrier against environmental factors while facilitating easy application. The versatile design of tubes allows for various dispensing options, making them user-friendly, particularly for consumers who may have difficulty with traditional packaging. The growth of the tube segment is being fueled by the increasing demand for over-the-counter topical applications and skin care products. Additionally, advancements in tube materials and design are improving product shelf life and safety, further enhancing their attractiveness within the pharmaceutical contract packaging market.

Others:

The "Others" category includes diverse packaging solutions such as cartons, sachets, and flexible packaging options that cater to unique product types within the pharmaceutical market. Each of these solutions provides distinct advantages, such as enhanced product protection, branding opportunities, and improved consumer convenience. As pharmaceutical companies seek to differentiate their products and enhance user experience, the demand for innovative and tailored packaging solutions in this category is expected to grow. Contract packaging providers who can offer a wide range of packaging types and customization options will be better positioned to meet the evolving needs of their clients.

By User

Pharmaceutical Companies:

Pharmaceutical companies represent a significant segment of the pharmaceutical contract packaging market, as they increasingly turn to outsourcing for packaging services. This trend stems from the desire to focus on core business functions such as research and development while leveraging the expertise of contract packagers to enhance product quality and compliance. Moreover, with the growing regulatory landscape, pharmaceutical companies are seeking partners who understand and can navigate complex packaging requirements. Contract packaging providers are responding by offering tailored solutions that address the unique challenges faced by pharmaceutical companies, thereby solidifying their position in the market.

Medical Device Companies:

Medical device companies are another key user segment in the pharmaceutical contract packaging market, as they require specialized packaging solutions that ensure product integrity and safety. The packaging of medical devices often involves stringent regulations and standards, necessitating the expertise of contract packagers who can deliver compliant and effective solutions. There is a growing trend towards the use of advanced packaging technologies, such as protective casings and tamper-evident packaging, to enhance product security. As the medical device industry continues to expand, the demand for specialized contract packaging services tailored to the unique requirements of medical devices is expected to rise significantly.

Biotechnology Companies:

Biotechnology companies, particularly those involved in the development of biologics and biosimilars, represent a growing user segment in the pharmaceutical contract packaging market. The unique nature of biologics, which often require cold chain logistics and specialized handling, necessitates innovative packaging solutions that can maintain product efficacy throughout the supply chain. Contract packaging providers are increasingly focusing on developing specialized packaging that adheres to strict regulatory guidelines while ensuring product safety. As the biotechnology sector continues to innovate and expand, the demand for sophisticated and compliant packaging solutions will likely drive growth in this segment.

Others:

The "Others" category encompasses a variety of users within the pharmaceutical contract packaging market, including research organizations and clinical research institutions. These entities often require specialized packaging for clinical trial materials, necessitating solutions that ensure product safety and compliance with regulatory standards. Additionally, the growing trend of personalized medicine is leading to an increase in demand for customized packaging solutions that cater to individual patient needs. Contract packagers who can offer agility and innovation in addressing the unique requirements of diverse user segments will play a crucial role in shaping the future of the pharmaceutical contract packaging market.

By Material Type

Plastic:

Plastic is one of the most widely used materials in pharmaceutical packaging due to its versatility, lightweight nature, and ability to be molded into various shapes and sizes. This material type is favored for its barrier properties, which protect drugs from moisture and contamination, thereby extending shelf life. Contract packaging providers are increasingly using advanced plastic formulations, such as polyethylene and polypropylene, in their offerings to meet specific regulatory requirements. The growth in demand for plastic packaging solutions is also a response to the rising need for cost-effective and efficient packaging options within the pharmaceutical industry.

Glass:

Glass packaging is highly regarded in the pharmaceutical industry for its inert properties, ensuring that it does not interact with the contents, which is critical for preserving the integrity of sensitive medications. Glass is particularly popular for injectable drugs and high-value biologics, where contamination risks must be minimized. The increasing demand for glass packaging is driven by the preference for premium and eco-friendly packaging solutions among pharmaceutical companies. However, the weight and fragility of glass can pose logistical challenges, prompting contract packagers to offer innovative glass packaging solutions that mitigate these drawbacks while maintaining product safety.

Paper & Paperboard:

Paper and paperboard materials are gaining traction in pharmaceutical packaging, particularly for secondary packaging solutions such as cartons and inserts. These materials offer an eco-friendly alternative to plastic, meeting the growing consumer demand for sustainable packaging options. Additionally, advancements in printing technology enable high-quality graphics and information to be included on paper and paperboard packaging, enhancing brand visibility and consumer engagement. As the push for sustainability continues, the demand for paper and paperboard packaging solutions is expected to rise, encouraging contract packagers to innovate within this material segment.

Metal:

Metal packaging, such as aluminum tubes and cans, offers exceptional protection against environmental factors and is prized for its durability and recyclability. This material type is commonly used for packaging ointments, creams, and other topical pharmaceuticals. The demand for metal packaging is driven by its ability to provide barrier protection while ensuring product integrity. Additionally, the growing emphasis on sustainability and recyclability is encouraging manufacturers to consider metal as a viable packaging option. Contract packaging companies are increasingly adopting metal packaging solutions to cater to the preferences of environmentally conscious consumers while meeting industry standards.

Others:

The "Others" category includes a range of specialized materials used in pharmaceutical packaging, such as biodegradable materials and advanced composites that offer unique benefits. These materials are being developed in response to the increasing demand for sustainable and innovative packaging solutions. As the pharmaceutical industry moves toward more eco-friendly practices, contract packaging providers are exploring alternative materials that minimize environmental impact without compromising product safety and efficacy. The ability to offer diverse and cutting-edge material options will be key to staying competitive in the pharmaceutical contract packaging market.

By Region

The North American pharmaceutical contract packaging market is currently the largest, driven by the presence of numerous pharmaceutical manufacturers and contract packagers within the region. The United States, in particular, is a significant contributor to this market due to its robust healthcare infrastructure and the high demand for innovative packaging solutions. The market in North America is expected to grow at a CAGR of 8% during the forecast period, bolstered by advancements in packaging technologies and regulatory compliance initiatives. Additionally, the increasing focus on sustainability among consumers and companies alike is prompting a shift toward more eco-friendly packaging solutions in the region.

In Europe, the pharmaceutical contract packaging market is also showing promising growth, owing to the presence of many established pharmaceutical firms and a strong focus on research and development. Countries like Germany, France, and the United Kingdom are leading contributors to this growth, driven by regulatory pressures and a heightened emphasis on patient safety. The European market is anticipated to benefit from innovations in packaging design and materials, as well as the rising trend towards outsourcing packaging processes. As a result, the European pharmaceutical contract packaging market is expected to grow at a CAGR of 7% from 2025 to 2035, reflecting a broader acceptance of contract packaging solutions across the continent.

Opportunities

The pharmaceutical contract packaging market presents numerous opportunities for growth, particularly as companies increasingly seek to enhance efficiency and reduce costs through outsourcing. With many pharmaceutical manufacturers facing challenges related to complex regulatory requirements and the need for specialized packaging solutions, contract packagers are well-positioned to fill these gaps. By offering tailored solutions that address specific product characteristics, contract packagers can play a vital role in the supply chain, ensuring compliance and enhancing overall product quality. Furthermore, as the demand for personalized medicine continues to rise, there is an opportunity for contract packaging firms to develop innovative packaging solutions that cater to individual patient needs, thereby creating a new market segment focused on patient-centric solutions.

Another significant opportunity for growth lies in the increasing demand for sustainable packaging solutions within the pharmaceutical industry. With consumers becoming more environmentally conscious, there is a growing need for contract packagers to offer eco-friendly materials and designs that minimize environmental impact. This shift towards sustainability not only aligns with consumer preferences but also addresses regulatory pressures for reduced plastic usage and increased recyclability. Contract packaging companies that invest in sustainable practices and technologies stand to gain a competitive advantage, as they can appeal to both environmentally conscious consumers and pharmaceutical companies seeking to enhance their corporate social responsibility initiatives.

Threats

Despite the promising prospects in the pharmaceutical contract packaging market, there are notable threats that could hinder growth. One of the primary challenges is the escalating competition among contract packaging firms, which can lead to pricing pressures and reduced profit margins. As more companies enter the market, standing out through innovative solutions and exceptional service is essential for maintaining a competitive edge. Additionally, the rapid pace of technological advancements can pose a threat to companies that are unable to keep up with evolving consumer demands and regulatory requirements. To address these challenges, contract packagers must remain agile and continuously invest in innovative solutions to meet the changing landscape of the pharmaceutical industry.

Another potential threat to the pharmaceutical contract packaging market is the global economic environment's volatility, which can impact investment and spending within the sector. Economic downturns or downturns in specific markets can lead pharmaceutical companies to reevaluate their outsourcing strategies, potentially slowing demand for contract packaging services. Furthermore, regulatory changes and compliance issues can present significant challenges, particularly for companies operating across multiple regions with varying requirements. As such, contract packagers must stay informed of regulatory developments and adapt their strategies accordingly to minimize risks and ensure sustained growth.

Competitor Outlook

• WestRock Company
• Gerresheimer AG
• Alcon Inc.
• Amcor PLC
• Sharp Packaging Solutions
• Catalent, Inc.
• Sonoco Products Company
• Baxter International Inc.
• Rondo Ganahl AG
• Pharmaceutical Packaging Corporation
• Delphi Healthcare Packaging
• Otsuka Pharmaceutical Factory, Inc.
• Printpack, Inc.
• Smurfit Kappa Group
• Schott AG

The competitive landscape of the pharmaceutical contract packaging market is characterized by the presence of various players, ranging from large multinational corporations to regional specialists. As companies strive to differentiate themselves in a crowded market, they are increasingly focusing on innovation, customer service, and the development of sustainable packaging solutions. The growing trend towards outsourcing has led to strategic partnerships and collaborations among contract packagers and pharmaceutical manufacturers, enabling both parties to leverage each other's strengths. Overall, the competitive environment is dynamic, requiring companies to continuously adapt and innovate to remain relevant and successful.

Among the key players, WestRock Company stands out for its comprehensive portfolio of packaging solutions, including sustainable materials and advanced manufacturing capabilities. The company has invested significantly in research and development to enhance its offerings, positioning itself as a leader in the market. Gerresheimer AG is another prominent player known for its expertise in glass and plastic packaging for pharmaceuticals and medical devices. The company emphasizes quality and safety, ensuring that its packaging solutions meet stringent regulatory requirements. Meanwhile, Catalent, Inc. is recognized for its specialized solutions in drug development and delivery, offering tailored contract packaging services that meet the unique needs of its clients.

Amcor PLC is also a notable player in the pharmaceutical contract packaging market, offering a wide range of packaging solutions designed to enhance product protection and compliance. The company has embraced sustainability as a core business strategy, developing eco-friendly packaging materials that appeal to environmentally conscious consumers. Additionally, Sharp Packaging Solutions is known for its expertise in pharmaceutical packaging and supply chain solutions, providing end-to-end services that streamline operations and improve efficiency. As the market continues to evolve, these companies and others will play a crucial role in shaping the future of the pharmaceutical contract packaging landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amcor PLC
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Schott AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Alcon Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Catalent, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Gerresheimer AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Printpack, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Rondo Ganahl AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 WestRock Company
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Smurfit Kappa Group
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Sonoco Products Company
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Baxter International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sharp Packaging Solutions
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Delphi Healthcare Packaging
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Otsuka Pharmaceutical Factory, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Pharmaceutical Packaging Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Contract Packaging Market, By User
    • 6.1.1 Pharmaceutical Companies
    • 6.1.2 Medical Device Companies
    • 6.1.3 Biotechnology Companies
    • 6.1.4 Others
  • 6.2 Pharmaceutical Contract Packaging Market, By Service Type
    • 6.2.1 Primary Packaging
    • 6.2.2 Secondary Packaging
    • 6.2.3 Tertiary Packaging
    • 6.2.4 Labeling and Kitting
    • 6.2.5 Others
  • 6.3 Pharmaceutical Contract Packaging Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Glass
    • 6.3.3 Paper & Paperboard
    • 6.3.4 Metal
    • 6.3.5 Others
  • 6.4 Pharmaceutical Contract Packaging Market, By Packaging Type
    • 6.4.1 Blisters
    • 6.4.2 Bottles
    • 6.4.3 Pouches
    • 6.4.4 Tubes
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Contract Packaging Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Contract Packaging market is categorized based on

By Service Type

• Primary Packaging
• Secondary Packaging
• Tertiary Packaging
• Labeling and Kitting
• Others

By Packaging Type

• Blisters
• Bottles
• Pouches
• Tubes
• Others

By User

• Pharmaceutical Companies
• Medical Device Companies
• Biotechnology Companies
• Others

By Material Type

• Plastic
• Glass
• Paper & Paperboard
• Metal
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• WestRock Company
• Gerresheimer AG
• Alcon Inc.
• Amcor PLC
• Sharp Packaging Solutions
• Catalent, Inc.
• Sonoco Products Company
• Baxter International Inc.
• Rondo Ganahl AG
• Pharmaceutical Packaging Corporation
• Delphi Healthcare Packaging
• Otsuka Pharmaceutical Factory, Inc.
• Printpack, Inc.
• Smurfit Kappa Group
• Schott AG